Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06015984
Other study ID # EBK-01
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date December 1, 2023
Est. completion date December 1, 2024

Study information

Verified date August 2023
Source Istanbul Gedik University
Contact Emek Bakanoglu Kalkavan
Phone 05447683055
Email emekkalkavan@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

There are two main treatments for end-stage renal disease (ESRD): dialysis and transplantation.Renal transplantation is the best and most preferred treatment for ESRD patients.Self management after renal transplantation is difficult. Individuals need appropriate care,education, counseling and support in order to change their behavior to cope with health problems during the transplantation process.The aim of nursing care and education is to enable the individual to acquire the knowledge, skills and attitude to independently carry out daily life activities and to adopt this as a lifestyle.Nursing care and education requires an interdisciplinary teamwork, and in this process, the nurse plays a key role as she constantly interacts with the donor, recipient and family.The research was designed as a randomized controlled experimental study with pretest-posttest design.A total of 60 nurses, 30 in the control group and 30 in the intervention group,who met the criteria for inclusion in the study, will form the sample of the study.After obtaining consent from the nurses in the intervention and control groups, they will be asked to fill out the Nurse InformationForm, the Patient-Centered Care Competency Scale and the Nurses Counseling Skills Scale. Aftercompleting the web-based training, intervention group nurses will be asked to fill in the Patient Centered Care Competency Scale and the Counseling Skills in Nurses Scale at the 1st and 3rd months. No training will be given to the nurses in the control group and they will be asked to fill the Patient-Centered Care Competency Scale and the Counseling Skills for Nurses Scale again.


Description:

There are two main treatments for end-stage renal disease (ESRD): dialysis and transplantation. Renal transplantation (RTx) is the best and most preferred treatment for ESRD patients. A successful RTx, made from a living or cadaver donor, improves the quality of life compared to dialysis and fully fulfills the function of the kidney.Self-management after renal transplantation is difficult. Individuals need appropriate care, education, counseling and support in order to change their behavior to cope with health problems during the transplantation process. The aim of nursing care and education is to enable the individual to acquire the knowledge, skills and attitude to independently carry out daily life activities and to adopt this as a lifestyle. Nursing care and education requires an interdisciplinary teamwork, and in this process, the nurse plays a key role as she constantly interacts with the donor, recipient and family.Today, technology-based methods are used to increase compliance with transplantation and are increasingly seen as valuable tools. The aim of this research is to develop and implement a web-based nurse training program for renal transplantation nurses and to examine the effect of this training on nurses' patient-centered care competence and counseling skills. The research was designed as a randomized controlled experimental study with pretest-posttest design. The population of the research will be 1870 nurses registered to the Turkish Nephrology, Dialysis and Transplantation Nurses Association. A total of 60 nurses, 30 in the control group and 30 in the intervention group, who met the criteria for inclusion in the study, will form the sample of the study.The research will be carried out on the website www.bobreknakliokulu.com, which will be developed after a preliminary interview with the nurses working in the renal transplantation clinics between April and August 2023, and they will be included in the web-based training as self-managed and asynchronous for 8 weeks.After obtaining consent from the nurses in the intervention and control groups, they will be asked to fill out the Nurse Information Form, the Patient-Centered Care Competency Scale and the Nurses Counseling Skills Scale. After completing the web-based training, intervention group nurses will be asked to fill in the Patient-Centered Care Competency Scale and the Counseling Skills in Nurses Scale at the 1st and 3rd months. No training will be given to the nurses in the control group and they will be asked to fill the Patient-Centered Care Competency Scale and the Counseling Skills for Nurses Scale again.It is expected that the renal transplantation nurses who receive this training will contribute positively to the increase of evidence-based knowledge and the development of clinical practices, the competence of patient-centered care and the management of counseling skills in line with clinical guidelines.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date December 1, 2024
Est. primary completion date September 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Having a maximum of 3 years of working experience in the Renal Transplantation clinic - Having a bachelor's degree in nursing Exclusion Criteria: - Nurses not completing all web-based nursing education modules - It will be caused by nurses not completing the 20-minute website usage period determined for each training module.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Traning
In order to participate in the training module, a user name and password will be given to the initiative group, the link to be used in the self-managed and asynchronous training platform will be shared, and it will be ensured that it participates in the web-based nurse training, and the training will last for eight weeks.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Istanbul Gedik University

References & Publications (9)

Chiaranai C. The Lived Experience of Patients Receiving Hemodialysis Treatment for End-Stage Renal Disease: A Qualitative Study. J Nurs Res. 2016 Jun;24(2):101-8. doi: 10.1097/jnr.0000000000000100. — View Citation

Chisholm-Burns M, Pinsky B, Parker G, Johnson P, Arcona S, Buzinec P, Chakravarti P, Good M, Cooper M. Factors related to immunosuppressant medication adherence in renal transplant recipients. Clin Transplant. 2012 Sep-Oct;26(5):706-13. doi: 10.1111/j.1399-0012.2011.01589.x. Epub 2012 Feb 10. — View Citation

Coresh J, Hu JR, Bello AK, Feldman HI, Fogo AB, Ganji MR, Harris DC, Levey AS, Okpechi IG, Stengel B, Thomas B, Wiecek A, Gansevoort RT. Action plan for determining and monitoring the prevalence of chronic kidney disease. Kidney Int Suppl (2011). 2017 Oct;7(2):63-70. doi: 10.1016/j.kisu.2017.07.002. Epub 2017 Sep 20. — View Citation

Horka K. Optimizing Care in Kidney Transplantation. Crit Care Nurs Clin North Am. 2022 Dec;34(4):443-451. doi: 10.1016/j.cnc.2022.08.003. Epub 2022 Oct 12. — View Citation

Kleber J, Cohen B. Reducing Waste and Increasing Sustainability in Health Care Settings. Am J Nurs. 2020 Apr;120(4):45-48. doi: 10.1097/01.NAJ.0000660032.02514.ec. — View Citation

Kohler B, Kellerer C, Schultz K, Wittmann M, Atmann O, Linde K, Hapfelmeier A, Schneider A. An Internet-Based Asthma Self-Management Program Increases Knowledge About Asthma. Dtsch Arztebl Int. 2020;117(5):64-71. doi: 10.3238/arztebl.2020.0064. — View Citation

Mathes T, Grosspietsch K, Neugebauer EAM, Pieper D. Interventions to increase adherence in patients taking immunosuppressive drugs after kidney transplantation: a systematic review of controlled trials. Syst Rev. 2017 Nov 29;6(1):236. doi: 10.1186/s13643-017-0633-1. — View Citation

Samarehfekri A, Dehghan M, Arab M, Ebadzadeh MR. Effect of Foot Reflexology on Pain, Fatigue, and Quality of Sleep after Kidney Transplantation Surgery: A Parallel Randomized Controlled Trial. Evid Based Complement Alternat Med. 2020 Aug 1;2020:5095071. doi: 10.1155/2020/5095071. eCollection 2020. — View Citation

Zala P, Schmid-Mohler G. Patients' Experiences of a Nurse-Led Self-Management Intervention After Kidney Transplantation. Nephrol Nurs J. 2022 Jan-Feb;49(1):45-57. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Patient-Centered Care Competency Scale Scale, by Hwang (2015); It was developed in order to determine the competencies of nurses in patient-centered care. The Turkish validity and reliability of the scale was made by Arslanoglu and Kirilmaz (2019). The Cronbach Alpha coefficient is 0.850. Patient-centered care competence consists of 17 questions and 4 sub-dimensions. Sub-dimensions; respecting the point of view (perspective) of patients (item 1-6), encouraging patient participation in care processes (items 7 and 11), ensuring patient comfort (items 12 and 14), and defending the rights of patients (15. - Article 17). Scale; It was designed as a 5-point Likert scale: 1-Strongly Disagree, 2-Disagree, 3-Undecided, 4-Agree, 5-Strongly Agree. 3 months
Secondary Counseling Skills Scale for Nurses After the item pool created by Avci and Kumcagiz in 2019 was finalized, it was applied to 204 nurses for explanatory factor analysis. The scale consists of 10 items and is a single factor. Afterwards, confirmatory factor analysis (CFA) was performed on 200 nurses. With confirmatory factor analysis, the fit index values of the single factor structure were found to be within acceptable limits (?2=94,785, sd=33, ?2/sd= 2.872, RMSEA=0.097, GFI=0.92, AGFI=0.86, CFI=0.92 and IFI=0.92) . The validity of the scale was examined by performing EFA and CFA. The reliability of the scale was examined with Cronbach's alpha coefficient and Split-half. Cronbach alpha was calculated as 0.88 and Split-half as 0.86. 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT04910867 - APOL1 Genetic Testing Program for Living Donors N/A
Completed NCT02723591 - To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients Phase 4
Completed NCT05945511 - Silent Gallbladder Stone in Kidney Transplantation Recipients: Should it be Treated?
Completed NCT02234349 - Bile Acids and Incretins in Pancreas Kidney Transplant Patients N/A
Completed NCT04496401 - PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus Phase 4
Recruiting NCT05917795 - Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates N/A
Not yet recruiting NCT05934383 - Safety and Efficacy of Ultrasound Renal Denervation in Kidney Transplantation Patients With Uncontrolled Hypertension N/A
Withdrawn NCT04936971 - Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response Phase 4
Not yet recruiting NCT04540640 - Oxygenated Machine Preservation in Kidney Transplantation N/A
Not yet recruiting NCT03090828 - Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease N/A
Recruiting NCT02908139 - Noninvasive Perioperative Monitoring of Arterial Stiffness, Volume and Nutritional Status in Stable Renal Transplant Recipients N/A
Completed NCT02560558 - Bela 8 Week Dosing Phase 4
Terminated NCT02417870 - Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation Phase 1/Phase 2
Recruiting NCT02154815 - Pre-emptive Kidney Transplantation Quality of Life N/A
Completed NCT02235571 - iChoose Decision Kidney Aid for End-Stage Renal Disease Patients N/A
Enrolling by invitation NCT01905514 - ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application in Solid Organ Transplant Patients N/A
Completed NCT02147210 - Chronic Transplant Glomerulopathy and Regulation of Expression of Ephrin B1 N/A
Recruiting NCT01699360 - The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients Phase 4
Completed NCT01655563 - Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation Phase 2
Completed NCT01672957 - ORANGE Study: An Observational Study on Renal Function in Kidney Transplant Patients on Immunosuppressive Therapy Containing CellCept (Mycophenolate Mofetil) N/A